FMR LLC - SPECTRUM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
FMR LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$12,423
+73.8%
12,941
+35.8%
0.00%
Q1 2023$7,146
+264.2%
9,526
+78.9%
0.00%
Q4 2022$1,9625,325
+541.6%
0.00%
Q3 2022$0
-100.0%
830
-74.9%
0.00%
Q2 2022$2,000
-50.0%
3,302
+10.8%
0.00%
Q1 2022$4,0002,981
+298000.0%
0.00%
Q3 2021$01
-98.3%
0.00%
Q2 2021$058
+31.8%
0.00%
Q1 2021$044
-12.0%
0.00%
Q4 2020$0
-100.0%
50
-98.8%
0.00%
Q2 2020$14,000
-89.1%
4,000
-92.7%
0.00%
Q1 2020$128,000
-97.5%
55,103
-96.0%
0.00%
-100.0%
Q4 2019$5,065,000
-70.5%
1,391,704
-32.7%
0.00%
-50.0%
Q3 2019$17,151,000
-3.7%
2,067,603
-0.0%
0.00%0.0%
Q2 2019$17,804,000
-22.0%
2,067,803
-3.2%
0.00%
-33.3%
Q1 2019$22,838,000
-23.5%
2,136,351
-37.4%
0.00%
-25.0%
Q4 2018$29,837,000
-52.2%
3,410,002
-8.2%
0.00%
-42.9%
Q3 2018$62,418,000
-50.8%
3,715,416
-38.6%
0.01%
-53.3%
Q2 2018$126,748,000
+7.2%
6,047,104
-17.7%
0.02%
+7.1%
Q1 2018$118,193,000
-11.4%
7,345,693
+4.4%
0.01%
-12.5%
Q4 2017$133,326,000
+178.2%
7,035,678
+106.6%
0.02%
+166.7%
Q3 2017$47,916,000
+407.5%
3,405,489
+168.7%
0.01%
+500.0%
Q2 2017$9,442,000
+11.1%
1,267,347
-3.0%
0.00%0.0%
Q1 2017$8,496,000
+38.6%
1,307,147
-5.5%
0.00%0.0%
Q4 2016$6,129,000
-68.9%
1,383,447
-67.3%
0.00%
-66.7%
Q3 2016$19,737,000
-29.2%
4,226,322
-0.4%
0.00%
-25.0%
Q2 2016$27,871,000
+3.3%
4,242,1470.0%0.00%0.0%
Q1 2016$26,980,000
+5.5%
4,242,1470.0%0.00%
+33.3%
Q4 2015$25,580,000
+0.8%
4,242,1470.0%0.00%
-25.0%
Q3 2015$25,368,000
-12.6%
4,242,1470.0%0.00%0.0%
Q2 2015$29,016,000
+12.7%
4,242,1470.0%0.00%
+33.3%
Q1 2015$25,750,000
-12.4%
4,242,1470.0%0.00%
-25.0%
Q4 2014$29,398,000
-14.9%
4,242,1470.0%0.00%
-20.0%
Q3 2014$34,531,000
+0.1%
4,242,1470.0%0.01%0.0%
Q2 2014$34,489,000
-4.1%
4,242,147
-7.5%
0.01%0.0%
Q1 2014$35,963,000
-32.7%
4,587,147
-24.0%
0.01%
-37.5%
Q4 2013$53,410,000
+3.2%
6,035,047
-2.1%
0.01%0.0%
Q3 2013$51,739,000
+11.2%
6,166,792
-1.2%
0.01%0.0%
Q2 2013$46,541,0006,238,6800.01%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,020,583$15,053,0001.77%
Piermont Capital Management Inc. 247,882$1,847,0000.53%
BARD ASSOCIATES INC 129,380$964,0000.44%
Sonora Investment Management, LLC 239,202$1,782,055,0000.34%
TFS CAPITAL LLC 97,526$727,0000.28%
Alambic Investment Management, L.P. 165,001$1,229,0000.15%
KENNEDY CAPITAL MANAGEMENT LLC 491,075$3,659,0000.07%
Renaissance Technologies 6,071,817$45,235,0000.06%
Granite Investment Partners, LLC 97,023$723,0000.05%
ClariVest Asset Management LLC 241,909$1,802,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders